• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

连续性肾脏替代治疗(CRRT)在肾静脉分流手术中的新应用病例报告。

A case report on the novel application of CRRT in renal vein shunting surgery.

作者信息

Tang Guangxu, Wang Hebin, Liu Luyao, Ji Chundong, Yi Junqiu, Zhang Lei, Liu Shiying

机构信息

Intensive Care Unit, The Affiliated Hospital of Panzhihua University, Panzhihua, 617000, PR China.

Department of Hepatology, The Affiliated Hospital of Panzhihua University, Panzhihua, 617000, PR China.

出版信息

Heliyon. 2025 Feb 11;11(4):e42645. doi: 10.1016/j.heliyon.2025.e42645. eCollection 2025 Feb 28.

DOI:10.1016/j.heliyon.2025.e42645
PMID:40040971
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11876912/
Abstract

BACKGROUND

Giant abdominal tumors exceeding 10 cm in diameter are rare and often involve several critical organs and vascular structures. The primary treatment is surgical excision, which presents substantial challenges, including organ preservation, hemorrhage control, and intact tumor removal.

CASE SUMMARY

We present a 46-year-old male with a massive abdominal mass invading the right kidney and inferior vena cava (IVC). To address this, we developed a novel technique using continuous renal replacement therapy (CRRT) renal vein (RV) shunt procedure. A temporary dialysis catheter was placed in the internal jugular vein to divert blood from the left RV to the superior vena cava. After excising the mass and part of the IVC, an artificial blood vessel was used to reconnect the left RV to the IVC. The urine output of the patient was normal during the surgery, and the renal function remained normal during the 343 days' follow-up period. This approach streamlined the surgical procedures, operating time, blood loss, and avoided systemic heparinization through regional citrate anticoagulation.

CONCLUSION

This innovative surgical technique is particularly effective for complex cases requiring simultaneous occlusion of the IVC and both RVs. It enhances patient safety and outcomes and has significant potential for broader application in urology and general surgery. This case highlights the value of surgical innovation in overcoming complex challenges and provides valuable insights for the medical community.

摘要

背景

直径超过10厘米的巨大腹部肿瘤较为罕见,且常累及多个重要器官和血管结构。主要治疗方法是手术切除,这带来了诸多重大挑战,包括器官保留、出血控制以及完整切除肿瘤。

病例摘要

我们报告一例46岁男性,患有巨大腹部肿块,侵犯右肾和下腔静脉(IVC)。为解决此问题,我们开发了一种使用连续性肾脏替代疗法(CRRT)肾静脉(RV)分流术的新技术。在颈内静脉置入一根临时透析导管,将血液从左肾静脉分流至上腔静脉。切除肿块及部分下腔静脉后,使用人工血管将左肾静脉重新连接至下腔静脉。手术过程中患者尿量正常,在343天的随访期内肾功能保持正常。这种方法简化了手术步骤、缩短了手术时间、减少了失血量,并通过局部枸橼酸盐抗凝避免了全身肝素化。

结论

这种创新的手术技术对于需要同时阻断下腔静脉和双侧肾静脉的复杂病例特别有效。它提高了患者的安全性和治疗效果,在泌尿外科和普通外科具有广泛应用的巨大潜力。本病例突出了手术创新在克服复杂挑战方面的价值,并为医学界提供了宝贵的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dff3/11876912/9755a4ea7f55/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dff3/11876912/b46398d257bd/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dff3/11876912/f3f985b9d5f4/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dff3/11876912/9755a4ea7f55/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dff3/11876912/b46398d257bd/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dff3/11876912/f3f985b9d5f4/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dff3/11876912/9755a4ea7f55/gr3.jpg

相似文献

1
A case report on the novel application of CRRT in renal vein shunting surgery.连续性肾脏替代治疗(CRRT)在肾静脉分流手术中的新应用病例报告。
Heliyon. 2025 Feb 11;11(4):e42645. doi: 10.1016/j.heliyon.2025.e42645. eCollection 2025 Feb 28.
2
Case report: Reconstruction of the left renal vein with resected autologous right renal vein interposition after excision of an inferior vena cava leiomyosarcoma.病例报告:下腔静脉平滑肌肉瘤切除术后采用自体右肾静脉移植重建左肾静脉。
Front Surg. 2022 Jul 26;9:913927. doi: 10.3389/fsurg.2022.913927. eCollection 2022.
3
Unusual Techniques for Preserving Surgical and Oncologic Safety in Hepatectomy of Advanced Adrenal Malignancy with Vena Cava and Liver Invasion.在伴有腔静脉和肝脏侵犯的晚期肾上腺恶性肿瘤肝切除术中,采用不同寻常的技术来保证手术和肿瘤学安全性。
Ann Surg Oncol. 2018 Oct;25(11):3324-3325. doi: 10.1245/s10434-018-6657-5. Epub 2018 Jul 17.
4
Anesthesia and perioperative management for giant adrenal Ewing's sarcoma with inferior vena cava and right atrium tumor thrombus: A case report.巨大肾上腺尤因肉瘤合并下腔静脉及右心房肿瘤血栓的麻醉及围手术期管理:一例报告
World J Clin Cases. 2022 Jan 14;10(2):643-655. doi: 10.12998/wjcc.v10.i2.643.
5
Pure retroperitoneal laparoscopic radical nephrectomy for right renal masses with renal vein and inferior vena cava thrombus.右肾肿块合并肾静脉和下腔静脉血栓的单纯后腹腔镜根治性肾切除术。
J Endourol. 2014 Jul;28(7):819-24. doi: 10.1089/end.2014.0066. Epub 2014 Apr 22.
6
A modified surgical technique of shortening renal ischemia time in left renal cancer patients with Mayo level II-IV tumor thrombus.一种用于缩短梅奥分级II-IV级肿瘤血栓的左肾癌患者肾缺血时间的改良手术技术。
BMC Surg. 2020 Jun 5;20(1):120. doi: 10.1186/s12893-020-00769-w.
7
Right Radical Nephrectomy With Level IV Thrombus by Combined 3D Laparoscopic and Mini-thoracotomy Approach.采用联合 3D 腹腔镜和小切口入路行右肾癌伴 IV 级血栓根治性切除术。
Urology. 2024 Jan;183:e316. doi: 10.1016/j.urology.2023.09.035. Epub 2023 Oct 12.
8
Robot-assisted Laparoscopic Inferior Vena Cava Thrombectomy: Different Sides Require Different Techniques.机器人辅助腹腔镜下下腔静脉血栓切除术:不同部位需要不同的技术。
Eur Urol. 2016 Jun;69(6):1112-9. doi: 10.1016/j.eururo.2015.12.001. Epub 2015 Dec 17.
9
Co-existence of the double inferior vena cava with complex interiliac venous communication and aberrant common hepatic artery arising from superior mesenteric artery: a case report.双下腔静脉合并复杂的髂间静脉交通及肠系膜上动脉发出的异常肝总动脉并存:一例报告
Folia Morphol (Warsz). 2018;77(1):151-155. doi: 10.5603/FM.a2017.0074. Epub 2017 Aug 23.
10
[HUGE RENAL ANGIOMYOLIPOMA COMPLICATED WITH COMMON ILIAC VEIN THROMBUS BECAUSE OF THE TUMOR PRESSURE].[巨大肾血管平滑肌脂肪瘤因肿瘤压迫并发髂总静脉血栓形成]
Nihon Hinyokika Gakkai Zasshi. 2017;108(2):96-100. doi: 10.5980/jpnjurol.108.96.

本文引用的文献

1
The Use of Extracorporeal Circulation to Facilitate the Resection of a Large Retroperitoneal Sarcoma With Major Vessel Involvement: A Single-Center Review of 20 Cases.体外循环在切除伴大血管受累的大型腹膜后肉瘤中的应用:单中心 20 例回顾性研究。
J Cardiothorac Vasc Anesth. 2023 Jul;37(7):1223-1229. doi: 10.1053/j.jvca.2023.03.009. Epub 2023 Mar 12.
2
Risk factors for the in-hospital mortality of CRRT-therapy patients with cardiac surgery-associated AKI: a single-center clinical study in China.心脏手术相关急性肾损伤行连续性肾脏替代治疗(CRRT)患者院内死亡的危险因素:一项中国单中心临床研究
Clin Exp Nephrol. 2022 Dec;26(12):1233-1239. doi: 10.1007/s10157-022-02274-1. Epub 2022 Sep 9.
3
Giant retroperitoneal liposarcoma surgical management.
巨大腹膜后脂肪肉瘤的外科治疗。
Ann R Coll Surg Engl. 2022 Feb;104(2):e54-e56. doi: 10.1308/rcsann.2021.0101. Epub 2021 Nov 22.
4
A Case Series of Preoperative Endovascular Stenting in Patients Undergoing Postchemotherapy Resection of Complex Oncologic Masses.化疗后切除复杂肿瘤患者的术前血管内支架置入术病例系列。
Eur Urol Oncol. 2020 Feb;3(1):1-6. doi: 10.1016/j.euo.2019.11.004. Epub 2019 Dec 28.
5
Clinicopathological characteristics and experience in the treatment of giant retroperitoneal liposarcoma: A case report and review of the literature.巨大多形性脂肪肉瘤的临床病理特征及治疗经验:病例报告及文献复习。
Cancer Biol Ther. 2017 Sep 2;18(9):660-665. doi: 10.1080/15384047.2017.1345388. Epub 2017 Jul 31.
6
Treatment of retroperitoneal sarcoma: current standards and new developments.腹膜后肉瘤的治疗:当前标准与新进展
Curr Opin Oncol. 2017 Jul;29(4):260-267. doi: 10.1097/CCO.0000000000000377.
7
Nomenclature for renal replacement therapy in acute kidney injury: basic principles.急性肾损伤中肾脏替代治疗的命名:基本原则
Crit Care. 2016 Oct 10;20(1):318. doi: 10.1186/s13054-016-1489-9.
8
Practical Issues for Retroperitoneal Sarcoma.腹膜后肉瘤的实际问题
Cancer Control. 2016 Jul;23(3):249-64. doi: 10.1177/107327481602300308.
9
Surgical management of primary retroperitoneal sarcoma.原发性腹膜后肉瘤的外科治疗。
Br J Surg. 2010 May;97(5):698-706. doi: 10.1002/bjs.6994.
10
Retroperitoneal soft tissue sarcomas: patterns of recurrence in 167 patients treated at a single institution.腹膜后软组织肉瘤:单机构治疗的167例患者的复发模式
Cancer. 2004 Jun 1;100(11):2448-55. doi: 10.1002/cncr.20269.